LEVOTHYROXINE SUPPRESSIVE THERAPY - HARMFUL AND USELESS OR HARMLESS AND USEFUL

被引：13

作者：

BARTALENA, L

PINCHERA, A

机构：

[1] Istituto di Endocrinologia, University of Pisa, Pisa, 56018, Viale del Tirreno, 64, Tirrenia

来源：

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION | 1994年 / 17卷 / 08期

关键词：

LT4 SUPPRESSIVE THERAPY; FREE THYROID HORMONES; TSH; BONE; HEART;

D O I：

10.1007/BF03349686

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：675 / 677

页数：3

共 16 条

[1]

ANDERSON PE, 1990, SURG GYNECOL OBSTET, V171, P309

[2] THYROID-HORMONES AND BONE MASS [J].

BARAN, DT ;

BRAVERMAN, LE .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 72 (06) :1182-1183

[3] FACTORS AFFECTING SUPPRESSION OF ENDOGENOUS THYROTROPIN SECRETION BY THYROXINE TREATMENT - RETROSPECTIVE ANALYSIS IN ATHYREOTIC AND GOITROUS PATIENTS [J].

BARTALENA, L ;

MARTINO, E ;

PACCHIAROTTI, A ;

GRASSO, L ;

AGHINILOMBARDI, F ;

BURATTI, L ;

BAMBINI, G ;

BRECCIA, M ;

PINCHERA, A .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1987, 64 (04) :849-855

[4] COMPARISON OF PLACEBO WITH L-THYROXINE ALONE OR WITH CARBIMAZOLE FOR TREATMENT OF SPORADIC NONTOXIC GOITER [J].

BERGHOUT, A ;

WIERSINGA, WM ;

DREXHAGE, HA ;

SMITS, NJ ;

TOUBER, JL .

LANCET, 1990, 336 (8709) :193-197

[5] CARDIAC EFFECTS OF LONG-TERM THYROTROPIN-SUPPRESSIVE THERAPY WITH LEVOTHYROXINE [J].

BIONDI, B ;

FAZIO, S ;

CARELLA, C ;

AMATO, G ;

CITTADINI, A ;

LUPOLI, G ;

SACCA, L ;

BELLASTELLA, A ;

LOMBARDI, G .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (02) :334-338

[6] LONG-TERM THYROXINE TREATMENT AND BONE-MINERAL DENSITY [J].

FRANKLYN, JA ;

BETTERIDGE, J ;

DAYKIN, J ;

HOLDER, R ;

OATES, GD ;

PARLE, JV ;

LILLEY, J ;

HEATH, DA ;

SHEPPARD, MC .

LANCET, 1992, 340 (8810) :9-13

[7] SUPPRESSIVE THERAPY WITH LEVOTHYROXINE FOR SOLITARY THYROID-NODULES - A DOUBLE-BLIND CONTROLLED CLINICAL-STUDY [J].

GHARIB, H ;

JAMES, EM ;

CHARBONEAU, JW ;

NAESSENS, JM ;

OFFORD, KP ;

GORMAN, CA .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (02) :70-75

[8] MORBIDITY IN PATIENTS ON L-THYROXINE - A COMPARISON OF THOSE WITH A NORMAL TSH TO THOSE WITH A SUPPRESSED TSH [J].

LEESE, GP ;

JUNG, RT ;

GUTHRIE, C ;

WAUGH, N ;

BROWNING, MCK .

CLINICAL ENDOCRINOLOGY, 1992, 37 (06) :500-503

[9] LEVOTHYROXINE THERAPY IN PATIENTS WITH THYROID-DISEASE [J].

MANDEL, SJ ;

BRENT, GA ;

LARSEN, PR .

ANNALS OF INTERNAL MEDICINE, 1993, 119 (06) :492-502

[10] CAREFULLY MONITORED LEVOTHYROXINE SUPPRESSIVE THERAPY IS NOT ASSOCIATED WITH BONE LOSS IN PREMENOPAUSAL WOMEN [J].

MARCOCCI, C ;

GOLIA, F ;

BRUNOBOSSIO, G ;

VIGNALI, E ;

PINCHERA, A .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (04) :818-823

← 1 2 →